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Erratum
Extensive Disease Small Cell Lung Cancer Dose-Response Relationships: Implications for Resistance Mechanisms: Erratum
In the article that appeared on page 1826 of the November 2010 issue, an author’s academic degree was incorrect. The author’s name should have
appeared as Constance Johnson, PhD.
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